证券代码：688222 证券简称：成都先导 公告编号：2025-039

Group 1 - The core point of the announcement is that Lhasa Economic and Technological Development Zone Huabo Medical Device Co., Ltd. has reduced its shareholding in Chengdu Xian Dao Pharmaceutical Development Co., Ltd. by 1% from 11.17% to 10.92% through a centralized bidding process, involving the sale of 1 million shares [1][2] - The reduction in shareholding is part of a previously disclosed plan and does not trigger a mandatory tender offer, as it is conducted by a shareholder holding more than 5% but not the largest shareholder [1][2] - The company will ensure that Huabo Medical Device adheres to relevant regulations during the share reduction period and will keep investors informed of any updates [2]